Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: ordesekimab | 0.81 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 13 Parkinson's papers of 8,092 | 0.65 |
| pathways Reactome | 1 pathway; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 5834
Sealed predictions
- IL15 in dopamine neurons, braak+0.20 (p 0.597) → +0.09 (p 0.813)receipt 5841
Swarm cases
receipt 5841: IL15 in dopamine neurons, braak
- power
- full sample +0.29 (p 0.250, n 18), 95% CI -0.21 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.35 (p 0.159, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.35 (p 0.159, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.47, sign flips 0; without severely affected donors +0.29 (p 0.250, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IL15 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts